MedTrace Logo

Alcohol Consumption After Bariatric Surgery

NCT06194175 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2024-01-08

No results posted yet for this study

Summary

A large body of studies indicate an increase in alcohol use disorder (AUD) rates after bariatric surgery. However, little information exists on the evolution of other drinking patterns after surgery and the psychological predictors of problematic drinking postoperatively. The identification of these factors is necessary for the implementation of prevention strategies regarding postoperative problematic alcohol use. The aim of this research is to examine the evolution of various drinking patterns after bariatric surgery as well as the psychological factors associated with AUD and an increase in postoperative alcohol consumption.

Conditions

  • Bariatric Surgery
  • Obesity
  • Alcohol Drinking

Interventions

PROCEDURE

Bariatric surgery

Participants whose application for bariatric surgery was accepted, regardless of the type of surgical intervention (e.g., sleeve gastrectomy, Roux-en-Y Gastric Bypass). This longitudinal study includes five measurement times: before surgery and then, 6 months, one year, one and a half years and two years after surgery. At each measurement time, participants are asked to respond to a set of online questionnaires. Responses are anonymous.

Sponsors & Collaborators

  • University of Liege

    lead OTHER

Principal Investigators

  • ER Esin · University of Liège (Research Unit for a life-Course perspective on Health & Education)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-30
Primary Completion
2026-03-30
Completion
2026-03-30

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06194175 on ClinicalTrials.gov